Publication | Closed Access
LGR5 is a promising biomarker for patients with stage I and II gastric cancer
16
Citations
0
References
2013
Year
Promising BiomarkerLgr5 Negative ExpressionPathologyCancer BiologyTumor BiologyOncologyGastrointestinal OncologyCancer Cell BiologyMolecular DiagnosticsFavorable Overall SurvivalMolecular OncologyCancer ResearchIi Gastric CancerBiomarker TargetStage ⅰCancer TreatmentCancer GeneticsCell BiologyTumor MicroenvironmentCancer GenomicsMedicine
0.05). LGR5 negative expression was significantly related to the favorable overall survival in stage Ⅰ and Ⅱ gastric cancer patients (P